November 13, 2014 - November 14, 2014
Double Tree Hotel
300 Army Navy Dr
Arlington, VA 22202
Agenda
Thursday, November, 13, 2014
| Time | Agenda Item | Presenter |
|---|---|---|
| 07:30 (30 min) |
Doors Open | Open to Public |
| 08:00 (10 min) |
Call to Order | Jay Menitove, MD Committee Chair |
| 08:10 (5 min) |
Roll Call | James Berger Executive Secretary |
Committee Business
| Time | Agenda Item | Presenter |
|---|---|---|
| 08:15 (20 min) |
Principal Deputy Assistant Secretary for Health’s Charge to the Committee | Wanda Jones, DrPH HHS Principal Deputy Assistant Secretary for Health |
Blood Donor Policy for Men who have Sex with Men
| Time | Agenda Item | Presenter |
|---|---|---|
| 08:35 (15 min) |
Introduction to MSM Blood Donor Deferral Policy Discussion | James Berger Executive Secretary |
| 08:50 (20 min) |
Origin, Evolution, and Effectiveness of MSM Blood Donor Deferral Policy | Alan E. Williams, Ph.D. Associate Director, Office of Blood Research and Review CBER, FDA |
| 09:10 (20 min) |
Current Epidemiology of HIV in the US | Amy Lansky, PhD, MPH Deputy Director for Surveillance, Epidemiology, and Laboratory Sciences Division of HIV/AIDS Prevention, CDC |
| 09:30 (40 min) |
Retrovirus Epidemiology Donor Study-II (REDS-II) TTI Marker Prevalence and Risk Factor Study | Simone Glynn, MD, MSc, MPH Branch Chief Blood Epidemiology and Clinical Therapeutics Branch National Heart, Blood, and Lung Institute |
| 10:10 | Break • 10 min | |
| 10:20 (40 min) |
Results of the Recipient Epidemiology and Donor Evaluation Study – III (REDS-III) Blood Donation Rules Opinion Study (Blood DROPS) | Brian Custer, PhD, MPH Associate Investigator Epidemiology and Health Research Policy Blood Systems Research Institute |
| 11:00 (20 min) |
Cognitive Interviewing Evaluation of the UDHQ: Results and Next Steps | Kristen Miller, Ph.D. and Stephanie Willson, Ph.D. National Center for Health Statistics |
| 11:20 (20 min) |
The Australia MSM Blood Donor Deferral Experience | Richard Benjamin MD, PhD, FRCPath Chief Medical Director American Red Cross |
| 11:40 (20 min) |
Discussion of MSM Blood Policy Deferral Options | Harvey Alter, MD Chief, Clinical Studies Associate Director of Research Department of Transfusion Medicine, NIH |
| 12:00 (45 min) |
Open Public Hearing (all sessions/ considerations) | |
| 12:45 | Lunch Break • 45 min | |
| 01:30 (2 hrs) |
Committee Questions, Discussion, and Recommendations | |
| 03:30 | Adjournment | Jay Menitove, MD Committee Chair |
Friday, November, 14, 2014
| Time | Agenda Item | Presenter |
|---|---|---|
| 07:30 (30 min) |
Doors Open | Open to Public |
| 08:00 (5 min) |
Call to Order | Jay Menitove, MD Committee Chair |
| 08:05 (10 min) |
Roll Call | James Berger Executive Secretary |
Advisory Committee Update
| Time | Agenda Item | Presenter |
|---|---|---|
| 08:15 (15 min) |
Subcommittee Update: Informed Consent in Transfusion and Transplantation | Jim Bowman, MD Medical Director Division of Transplantation HHS/HRSA |
Hemoglobin S Testing in Blood Donors
| Time | Agenda Item | Presenter |
|---|---|---|
| 08:30 (30 min) |
Hemoglobin S Testing in Blood Donors | Orieji Illoh, MD Deputy Director Division of Blood Components and Devices FDA/CBER/OBRR |
| 09:00 (30 min) |
Presidential Commission for the Study of Bioethical Issues: Ethical Implications of Incidental Findings | Lisa M. Lee, PhD, MS Executive Director Presidential Commission for the Study of Bioethical Issues |
| 09:30 (30 min) |
Ethical Issues in Sickle Screening | Norman Fost, MD, MPH Professor Emeritus Departments of Pediatrics and Medical History & Bioethics University of Wisconsin School of Medicine and Public Health |
| 10:00 (30 min) |
Returning hematoglobinopathy results to blood donors: ethical considerations | Steven Joffe, MD, MPH Emanuel and Robert Hart Associate Professor Vice-Chair, Department of Medical Ethics and Health Policy University of Pennsylvania Perelman School of Medicine |
| 10:30 | Break • 10 min | |
| 10:40 (20 min) |
Sickle Cell Testing in Independent Blood Centers | Louis M. Katz, MD Chief Medical Officer America’s Blood Center |
| 11:00 (30 min) |
Blood Center Perspective | Yelena Ginzburg, MD Medical Director, Medical Programs and Services New York Blood Center |
| 11:30 (30 min) |
Sourcing and Transfusing RBC for Selected Populations and Responding to Donors with Positive Sickle Screening | Naomi L. C. Luban, M.D. Director, Transfusion Medicine, The Edward J. Miller Jr. Blood Donor Center Vice Chair for Academic Affairs, Children’s National Medical Center Professor, Pediatrics and Pathology, The George Washington University School of Medicine |
| 12:00 (15 min) |
Patient and Family Perspective on Hemoglobin S testing | Larry Allen Executive Secretary, Committee of Ten Thousand |
| 12:15 | Lunch Break • 45 min | |
| 01:00 (25 min) |
Open Public Hearing (all sessions/ considerations) |
Emerging Infectious Diseases
| Time | Agenda Item | Presenter |
|---|---|---|
| 01:25 (25 min) |
Public Health Perspective on a Progressively Emerging Threat | Alfred DeMaria, MD Medical Director, Bureau of Infectious Disease Massachusetts Department of Public Health |
| 01:50 (25 min) |
Transfusion Transmitted Babesiosis: Perspectives from the NYBC Experience | Beth Shaz, MD Chief Medical Officer New York Blood Center |
| 02:15 (25 min) |
Ethical Issues for selective Infectious Disease Testing | Richard Benjamin MD, PhD, FRCPath Chief Medical Director American Red Cross |
| 02:40 (2 hrs) |
Committee Questions, Discussion, and Recommendations | |
| 04:40 | Adjournment | Jay Menitove, MD Committee Chair |
